PHARMAnetwork logo
GLOBAL CDMO & PHARMA OUTSOURCING  
Menu
  • Industry Insights
    • Market Intelligence
    • Corporate Strategy
    • Investments & Capex
    • Finance & M&A
    • Regulatory Affairs
    • Legal & Compliance
  • Magazine
    • Latest Issue
    • Archive
    • Editions
    • Editorial Line
  • Events
  • For advertisers
    • Why PHARMAnetwork
    • MediaKit
    • Contact us
  • About PHARMAnetwork
    • Who We Are
    • Editorial Philosophy
    • Contact us

PHARMAnetwork magazine - last issue

PHARMAnetwork magazine: n° 70&71 October 2026 - Content

Market Intelligence
10 Advancing Global Health Solutions Through a Networked Model: A Nimble Approach with CRDMOs and Commercial Partners
Financial & M&A
16 Listed CDMOs – H1 2026: Growth and a New Hierarchy
Corporate Strategy
30 CDMO 2026 and Beyond: Strategic choices to expand their markets
32 One Molecule, Multiple Scientific Lenses: Why Scientific Breadth Matters in Modern CDMO Partnerships
36 Growth Through Integration by Design
42 Famar and the New Industrial Cycle for CDMOs
46 The Deal Architect
52 Building Beyond Capacity
56 Building the Operating Model for a €2 Billion CDMO: How CordenPharma is Scaling Global Growth
62 The Future of Sterile Fill-Finish CDMOs: Trends Shaping the Next Generation of Aseptic Manufacturing
68 Development Strategies for an Era of Disrupted Supply Chains
74 Partnering for the Next Generation of Pharmaceutical Innovation
78 Beyond Capacity: What Pharmaceutical Companies Should Expect from their CDMO
82 The CDMO of the Future is Already Here
Legal
90 Liability for Defective Products: A New Framework for CDMOs to Anticipate
Read our last issue

PHARMAnetwork

  • About us
  • Editorial Philosophy
  • Contact

Editorial content

  • Industry Insights
  • Magazine - last issue
  • Events

For advertisers

  • Why PHARMAnetwork
  • Contact us
© 1997-2026 PHARMAnetwork – All rights reserved.
Privacy Policy | Terms of Use
International media on CDMOs & Contract pharmaceutical